Bioventus: Strategic Moves Amidst Financial Challenges Justify Hold Rating

TipRanksDec 17 18:36 · Ratings

J.P. Morgan Upgrades Bioventus(BVS.US) to Hold Rating, Raises Target Price to $13

Futu NewsDec 17 18:34 · Ratings

Express News | Bioventus Inc : JP Morgan Raises to Neutral From Underweight; Raises Target Price to $13 From $12

BreakingsDec 17 13:29

Wall Street Analysts Think Bioventus (BVS) Could Surge 26.03%: Read This Before Placing a Bet

Yahoo FinanceDec 6 22:55

Earnings Call: Bioventus Reports Robust Q3 Growth, Raises Full-year Guidance

InvestingNov 7 02:24

Bioventus Is Maintained at Buy by Canaccord Genuity

Dow JonesNov 7 01:58 · Ratings